December 13, 2021
December 7, 2021
Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for the Fourth Quarter and Full Year Fiscal 2021
Company To Reschedule Its Financial Results Conference Call WEST LAFAYETTE, Ind., Dec. 07, ...
November 29, 2021
Inotiv, Inc. to Report Fourth Quarter Fiscal 2021 Financial Results and Host Conference Call on Tuesday, December 7, 2021
WEST LAFAYETTE, Ind., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing ...
November 10, 2021
Inotiv, Inc. Announces Opening of Newly-Constructed Laboratories at St. Louis Facility
WEST LAFAYETTE, Ind., Nov. 10, 2021 (GLOBE NEWSWIRE) -- November 10, 2021 -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research ...
November 5, 2021
Inotiv, Inc. Shareholders Approve Acquisition of Envigo
WEST LAFAYETTE, Ind., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing ...
November 5, 2021
Inotiv, Inc. Completes Purchase of Envigo
WEST LAFAYETTE, Ind. and INDIANAPOLIS, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Inotiv, ...
November 5, 2021
Inotiv, Inc. completes purchase of Envigo
Creates a full-spectrum discovery-to-approval solution for drug developers WEST LAFAYETTE, Ind. and INDIANAPOLIS, Nov. 05, 2021 (GLOBE NEWSWIRE) –
November 2, 2021
Inotiv, Inc. to Participate in Upcoming Investor Conferences
WEST LAFAYETTE, Ind., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing ...
October 4, 2021
Inotiv, Inc. Announces Expansion of In Vivo Pharmacology Offering with Acquisition of Plato BioPharma, Inc.
WEST LAFAYETTE, Ind., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing ...
September 28, 2021
Envigo announces collaboration with Biocytogen to distribute the B-NDG triple immunodeficient and humanizable mouse mode
Indianapolis, Indiana, USA, September 28th, 2021 — Envigo RMS Holding Corp. (or Envigo) announces a ...
SCIENTIFIC INSIGHTS
Keep up-to-date with the latest industry thinking and scientific insights
Explore today Explore today
More than 90 years of working together, to build a healthier and safer world
Explore our history Explore our history
Subscribe to updates from Inotiv
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
